Table 5 Frequency (%) of 60-month postoperative complications in the surgical groups
From: Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up
MMC group | OLO group | P a | |
|---|---|---|---|
Cataract | 5(25 %) | 3(15 %) | 0.694 |
Age-related macular degeneration | 2(10 %) | 2(10 %) | 1.0 |
Loss > 1 line VA | 5(25 %) | 4(20 %) | 1.0 |
Thin avascular bleb | 6(30 %) | 2(10 %) | 0.235 |